27/01/2025
Our favorite startups from Pear VC’s invitational demo day
Over those years, the small but mighty program has helped launch numerous companies like Viz.ai, whose FDA-approved AI can diagnose strokes (and was valued at $1.2 billion in 2022); relationship management company Affinity, which raised an $80 million Series C at a $620 million valuation, according to PitchBook data; and Valar Labs, which uses AI to help doctors make cancer-treatment decisions (it closed a $22 million Series A in May).